NYSE:THC - Tenet Healthcare Stock Price, Price Target & More

$23.28 -1.19 (-4.86 %)

(As of 04/26/2018 04:00 PM ET)

Previous Close$24.47

Today's Range$22.66 - $23.98

52-Week Range$12.25 - $25.24

Volume2.94 million shs

Average Volume2.33 million shs

Market Capitalization$2.42 billion

P/E Ratio28.74

Dividend YieldN/A

Beta0.8

About Tenet Healthcare (NYSE:THC)

Tenet Healthcare Corporation operates as a diversified healthcare services company. It operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The company's general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. It also provides intensive and critical care, and coronary care units; physical therapy, orthopedic, oncology, and outpatient services; tertiary care services, including cardiothoracic surgery, neonatal intensive care, and neurosciences; quaternary care in heart, liver, kidney, and bone marrow transplants areas; tertiary and quaternary pediatric, and burn services; and limb-salvaging vascular procedures, acute level 1 trauma services, intravascular stroke care, minimally invasive cardiac valve replacement, imaging technology, and telemedicine access for various medical specialties. In addition, the company operates ambulatory surgery and urgent care centers, imaging centers, and surgical hospitals, as well as Aspen's hospitals and clinics; and offers healthcare business process services in the areas of hospital and physician revenue cycle management, as well as value-based care solutions to healthcare systems, individual hospitals, physician practices, self-insured organizations, health plans, and other entities. Further, it offers accounts receivable and health information management, and revenue integrity and patient financial services; patient communications and engagement services; and clinical integration, financial risk management, and population health management services. As of December 31, 2017, the company operated 76 hospitals, 20 surgical hospitals, and approximately 470 outpatient centers, as well as 247 ambulatory surgery, 34 urgent care, and 23 imaging centers in the United States; and 9 private hospitals and clinics in the United Kingdom. The company was founded in 1967 and is headquartered in Dallas, Texas.

Receive THC News and Ratings via Email

Sign-up to receive the latest news and ratings for THC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry General medical & surgical hospitals

Sub-IndustryHealth Care Facilities

SectorMedical

SymbolNYSE:THC

CUSIP88033G40

Webwww.tenethealth.com

Phone469-893-2200

Debt

Debt-to-Equity Ratio27.44%

Current Ratio1.29%

Quick Ratio1.22%

Price-To-Earnings

Trailing P/E Ratio28.74

Forward P/E Ratio24.77

P/E Growth2.02

Sales & Book Value

Annual Sales$19.18 billion

Price / Sales0.12

Cash Flow$9.6198 per share

Price / Cash2.42

Book Value$5.34 per share

Price / Book4.36

Profitability

EPS (Most Recent Fiscal Year)$0.81

Net Income$-704,000,000.00

Net Margins-3.67%

Return on Equity9.69%

Return on Assets0.34%

Miscellaneous

Employees126,000

Outstanding Shares101,110,000

How to Become a New Pot Stock Millionaire

Tenet Healthcare (NYSE:THC) Frequently Asked Questions

What is Tenet Healthcare's stock symbol?

Tenet Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "THC."

How were Tenet Healthcare's earnings last quarter?

Tenet Healthcare (NYSE:THC) posted its quarterly earnings results on Monday, February, 26th. The company reported $1.40 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $1.25 by $0.15. The firm had revenue of $4.98 billion for the quarter, compared to analyst estimates of $4.85 billion. Tenet Healthcare had a negative net margin of 3.67% and a positive return on equity of 9.69%. Tenet Healthcare's revenue for the quarter was up 2.4% compared to the same quarter last year. During the same quarter last year, the firm posted $0.06 earnings per share. View Tenet Healthcare's Earnings History.

When is Tenet Healthcare's next earnings date?

Tenet Healthcare is scheduled to release their next quarterly earnings announcement on Monday, April, 30th 2018. View Earnings Estimates for Tenet Healthcare.

What guidance has Tenet Healthcare issued on next quarter's earnings?

Tenet Healthcare updated its FY18 earnings guidance on Monday, February, 26th. The company provided EPS guidance of $0.73-$1.07 for the period, compared to the Thomson Reuters consensus estimate of $0.78. The company issued revenue guidance of $17.9-$18.3 billion, compared to the consensus revenue estimate of $18.26 billion.Tenet Healthcare also updated its Q1 guidance to ($0.10)-$0.05 EPS.

What price target have analysts set for THC?

16 brokerages have issued 12 month target prices for Tenet Healthcare's shares. Their predictions range from $15.00 to $30.00. On average, they expect Tenet Healthcare's stock price to reach $22.2667 in the next twelve months. View Analyst Ratings for Tenet Healthcare.

Are investors shorting Tenet Healthcare?

Tenet Healthcare saw a drop in short interest in the month of March. As of March 15th, there was short interest totalling 21,496,017 shares, a drop of 9.9% from the February 28th total of 23,848,997 shares. Based on an average daily volume of 2,705,248 shares, the days-to-cover ratio is presently 7.9 days. Currently, 21.7% of the company's stock are short sold.

Who are some of Tenet Healthcare's key competitors?

Some companies that are related to Tenet Healthcare include Hospital Co. of America (HCA), Universal Health Services (UHS), LifePoint Health (LPNT), Surgery Partners (SGRY), Community Health Systems (CYH) and Quorum Health (QHC).

Who are Tenet Healthcare's key executives?

Tenet Healthcare's management team includes the folowing people:

Mr. Ronald A. Rittenmeyer, Exec. Chairman & CEO (Age 71)
Mr. Daniel J. Cancelmi, Chief Financial Officer (Age 55)
Ms. Audrey T. Andrews, Sr. VP & Gen. Counsel (Age 51)
Mr. Keith B. Pitts, Vice Chairman (Age 60)
Mr. Jason Eric Evans, Pres of Hospital Operations (Age 41)

Has Tenet Healthcare been receiving favorable news coverage?

Media coverage about THC stock has trended somewhat positive recently, Accern Sentiment reports. Accern scores the sentiment of press coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Tenet Healthcare earned a news impact score of 0.11 on Accern's scale. They also assigned news articles about the company an impact score of 46.42 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near term.

Who are Tenet Healthcare's major shareholders?

Tenet Healthcare's stock is owned by a number of of institutional and retail investors. Top institutional investors include GLENVIEW CAPITAL MANAGEMENT, LLC (17.74%) and GLENVIEW CAPITAL MANAGEMENT, LLC (17.77%). Company insiders that own Tenet Healthcare stock include Ashish Dave, George Fredrick Smitherman, Peter M Wilver and Ronald A Rittenmeyer. View Institutional Ownership Trends for Tenet Healthcare.

How do I buy shares of Tenet Healthcare?

Shares of THC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Tenet Healthcare's stock price today?

One share of THC stock can currently be purchased for approximately $23.28.

How big of a company is Tenet Healthcare?

Tenet Healthcare has a market capitalization of $2.42 billion and generates $19.18 billion in revenue each year. The company earns $-704,000,000.00 in net income (profit) each year or $0.81 on an earnings per share basis. Tenet Healthcare employs 126,000 workers across the globe.

How can I contact Tenet Healthcare?

Tenet Healthcare's mailing address is 1445 ROSS AVENUE SUITE 1400, DALLAS TX, 75202. The company can be reached via phone at 469-893-2200 or via email at [email protected]

MarketBeat Community Rating for Tenet Healthcare (THC)

Community Ranking:		2.2 out of 5 ( )
Outperform Votes:		401 (Vote Outperform)
Underperform Votes:		522 (Vote Underperform)
Total Votes:		923

MarketBeat's community ratings are surveys of what our community members think about Tenet Healthcare and other stocks. Vote "Outperform" if you believe THC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe THC will underperform the S&P 500 over the long term. You may vote once every thirty days.

Tenet Healthcare (NYSE:THC) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

16 Wall Street analysts have issued ratings and price targets for Tenet Healthcare in the last 12 months. Their average twelve-month price target is $22.2667, suggesting that the stock has a possible downside of 4.35%. The high price target for THC is $30.00 and the low price target for THC is $15.00. There are currently 2 sell ratings, 7 hold ratings and 7 buy ratings for the stock, resulting in a consensus rating of "Hold."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Hold	Hold	Hold	Hold
Consensus Rating Score:	2.31	2.31	2.29	2.40
Ratings Breakdown:	2 Sell Rating(s) 7 Hold Rating(s) 7 Buy Rating(s) 0 Strong Buy Rating(s)	2 Sell Rating(s) 7 Hold Rating(s) 7 Buy Rating(s) 0 Strong Buy Rating(s)	2 Sell Rating(s) 6 Hold Rating(s) 6 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 9 Hold Rating(s) 6 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$22.2667	$21.4667	$18.3077	$20.5714
Price Target Upside:	4.35% downside	10.82% downside	14.49% upside	56.44% upside

Tenet Healthcare (NYSE:THC) Consensus Price Target History

Price Target History for Tenet Healthcare (NYSE:THC)

Tenet Healthcare (NYSE:THC) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/17/2018	SunTrust Banks	Reiterated Rating	Hold	$27.00	Low
3/22/2018	Mizuho	Reiterated Rating	Buy	$29.00	High
3/5/2018	JPMorgan Chase	Boost Price Target	Underweight -> Underweight	$15.00 -> $18.00	Low
3/1/2018	Piper Jaffray	Reiterated Rating	Hold	$21.00	High
3/1/2018	Citigroup	Boost Price Target	Buy -> Buy	$19.00 -> $27.00	Low
2/28/2018	Morgan Stanley	Boost Price Target	Underweight -> Underweight	$15.00 -> $16.00	Medium
2/28/2018	Wells Fargo	Boost Price Target	Market Perform -> Market Perform	$20.00 -> $22.00	High
2/28/2018	Raymond James	Upgrade	Market Perform -> Outperform	$30.00	High
2/27/2018	Jefferies Group	Set Price Target	Buy	$23.00	Low
1/3/2018	Goldman Sachs	Initiated Coverage	Neutral -> Neutral	$15.00	High
12/20/2017	Leerink Swann	Reiterated Rating	Buy	$27.00	Low
11/21/2017	William Blair	Reiterated Rating	Market Perform		N/A
11/13/2017	Royal Bank of Canada	Lower Price Target	Sector Perform	$19.00 -> $17.00	N/A
11/2/2017	Credit Suisse Group	Initiated Coverage	Neutral	$15.00	N/A
9/28/2017	Robert W. Baird	Reiterated Rating	Buy	$23.00	High
9/1/2017	Deutsche Bank	Reiterated Rating	Buy	$24.00	Low
1/11/2017	UBS	Reiterated Rating	Buy	$26.00 -> $24.00	N/A
11/9/2016	Bank of America	Downgrade	Buy -> Neutral	$32.00 -> $25.00	N/A
10/25/2016	Wolfe Research	Initiated Coverage	Market Perform		N/A
8/19/2016	Barclays	Reiterated Rating	Buy	$39.00	N/A
6/13/2016	Ladenburg Thalmann	Upgrade	Not Rated -> Underperform		N/A
5/16/2016	Sterne Agee CRT	Reiterated Rating	Buy		N/A

(Data available from 4/26/2016 forward)

Tenet Healthcare (NYSE:THC) Earnings History and Estimates Chart

Earnings by Quarter for Tenet Healthcare (NYSE:THC)

Tenet Healthcare (NYSE:THC) Earnings Estimates

2018 EPS Consensus Estimate: $0.93
2019 EPS Consensus Estimate: $1.74

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	4	($0.03)	$0.03	$0.01
Q2 2018	4	$0.10	$0.29	$0.18
Q3 2018	4	($0.03)	$0.28	$0.14
Q4 2018	4	$0.29	$0.93	$0.59
Q1 2019	2	($0.03)	($0.01)	($0.02)
Q2 2019	2	$0.24	$0.31	$0.28
Q3 2019	2	$0.24	$0.36	$0.30
Q4 2019	2	$1.06	$1.30	$1.18

Tenet Healthcare (NYSE THC) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
4/30/2018		$0.09					N/A
2/26/2018	Q4 2017	$1.25	$1.40	$4.8518 billion	$4.9780 billion	View	N/A
11/6/2017	Q3 2017	($0.40)	($0.17)	$4.9445 billion	$4.5860 billion	View	N/A
10/27/2017	Q3 2017	($0.38)	($0.17)	$4.7264 billion	$4.5860 billion	View	N/A
8/7/2017	Q2 2017	($0.17)	($0.17)	$4.9012 billion	$14.8020 billion	View	Listen
5/1/2017	Q1 2017	($0.5230)	($0.27)	$4.8441 billion	$4.8130 billion	View	Listen
2/27/2017	Q416	$0.22	$0.06	$4.95 billion	$4.86 billion	View	N/A
10/31/2016	Q316	$0.17	$0.16	$2.28 billion	$4.85 billion	View	N/A
8/1/2016	Q216	$0.52	$0.38	$4.82 billion	$4.87 billion	View	N/A
5/2/2016	Q116	$0.34	$0.45	$4.79 billion	$5.0440 billion	View	N/A
2/22/2016	Q415	$0.34	$0.35	$4.82 billion	$5.2060 billion	View	Listen
11/2/2015	Q315	$0.27	$0.29	$4.67 billion	$4.6920 billion	View	N/A
8/3/2015	Q215	$0.44	$0.75	$4.37 billion	$4.4920 billion	View	N/A
5/4/2015	Q115	$0.31	$0.67	$4.33 billion	$4.43 billion	View	N/A
2/23/2015	Q414	$1.18	$1.03	$4.34 billion	$4.8240 billion	View	N/A
11/3/2014	Q314	$0.10	$0.09	$4.02 billion	$4.18 billion	View	Listen
8/4/2014	Q214	$0.01	($0.27)	$3.94 billion	$4.04 billion	View	N/A
5/5/2014	Q114	($0.14)	($0.12)	$3.91 billion	$3.93 billion	View	Listen
2/24/2014	Q413	$0.37	$0.49	$3.87 billion	$3.89 billion	View	N/A
11/5/2013	Q313	$0.45	$0.45	$2.38 billion	$2.6180 billion	View	Listen
8/6/2013	Q2 2013	$0.75	($0.49)	$2.46 billion	$2.42 billion	View	N/A
4/30/2013	Q1 2013	$0.31	$0.33	$2.46 billion	$2.5940 billion	View	Listen
2/26/2013	Q4 2012	$0.68	$0.45	$2.34 billion	$2.33 billion	View	Listen
11/7/2012	Q312	$0.32	$0.34	$2.4157 billion	$2.4270 billion	View	N/A
8/7/2012		$0.05	$0.10			View	N/A
5/8/2012		$0.10	$0.13			View	N/A
2/28/2012		$0.14	$0.10			View	N/A
11/1/2011			$0.04			View	N/A
8/2/2011		$0.08	$0.09			View	N/A
5/3/2011		$0.14	$0.17			View	N/A
2/25/2011		$0.08	$0.14			View	N/A
11/2/2010	Q3 2010	$0.20	($0.04)			View	N/A
8/3/2010	Q2 2010	$0.24	$0.28			View	N/A
5/4/2010	Q1 2010	$0.28	$0.65			View	N/A
2/23/2010	Q4 2009	$0.04	$0.30			View	N/A
11/3/2009	Q3 2009	($0.08)	$0.12			View	N/A
8/4/2009	Q2 2009		$0.18			View	N/A
5/5/2009	Q1 2009	$0.12	$0.40			View	N/A
2/24/2009	Q4 2008	($0.12)	($0.08)			View	N/A
11/3/2008	Q3 2008	($0.12)	($0.27)			View	N/A
8/5/2008	Q2 2008	($0.04)	($0.03)			View	N/A
5/6/2008	Q1 2008	$0.04	$0.17			View	N/A
2/26/2008	Q4 2007	($0.12)	($0.42)			View	N/A

(Earnings results data provided by Zacks Investment Research)

Tenet Healthcare (NYSE:THC) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

Tenet Healthcare (NYSE THC) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.20%

Insider Trading History for Tenet Healthcare (NYSE:THC)

Institutional Ownership by Quarter for Tenet Healthcare (NYSE:THC)

Tenet Healthcare (NYSE THC) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/9/2018	Ashish Dave	Director	Sell	75,000	$1.40	$105,000.00
2/5/2018	George Fredrick Smitherman	Director	Sell	39,000	$0.39	$15,210.00
1/30/2018	George Fredrick Smitherman	Director	Sell	14,300	$2.02	$28,886.00
1/25/2018	George Fredrick Smitherman	Director	Buy	125,000	$38.50	$4,812,500.00
1/15/2018	George Fredrick Smitherman	Director	Sell	1,300	$38.50	$50,050.00
11/11/2016	Ronald A Rittenmeyer	Director	Buy	15,000	$14.35	$215,250.00	23,783
11/9/2016	Peter M Wilver	Director	Buy	5,000	$15.19	$75,950.00	5,000
11/13/2015	Glenview Capital Management, L	Major Shareholder	Buy	900,000	$32.56	$29,304,000.00
10/22/2015	Glenview Capital Management, L	Major Shareholder	Buy	500,000	$29.71	$14,855,000.00
9/30/2015	Glenview Capital Management, L	Major Shareholder	Buy	500,000	$36.30	$18,150,000.00
8/25/2015	Glenview Capital Management, L	Major Shareholder	Buy	500,000	$48.39	$24,195,000.00
7/14/2015	Trevor Fetter	CEO	Sell	96,477	$60.40	$5,827,210.80
7/13/2015	Trevor Fetter	CEO	Sell	88,004	$60.08	$5,287,280.32
7/6/2015	Trevor Fetter	CEO	Sell	83,443	$60.02	$5,008,248.86
6/25/2015	Glenview Capital Management, L	Major Shareholder	Buy	979,482	$54.93	$53,802,946.26
6/25/2015	Trevor Fetter	CEO	Sell	47,711	$55.02	$2,625,059.22
6/4/2015	R. Scott Ramsey	Insider	Sell	5,650	$51.64	$291,766.00
8/18/2014	Trevor Fetter	CEO	Sell	33,642	$60.01	$2,018,856.42
8/14/2014	Britt T Reynolds	Insider	Sell	8,028	$58.49	$469,557.72
8/8/2014	Audrey T Andrews	SVP	Sell	2,208	$56.31	$124,332.48
8/8/2014	Daniel J Cancelmi	CFO	Sell	12,291	$56.88	$699,112.08
8/8/2014	R. Scott Ramsey	Insider	Sell	2,083	$56.27	$117,210.41
8/7/2014	Trevor Fetter	CEO	Sell	138,665	$56.12	$7,781,879.80
7/25/2014	Trevor Fetter	CEO	Sell	41,000	$51.34	$2,104,940.00
6/9/2014	Britt T Reynolds	Insider	Sell	35,000	$49.82	$1,743,700.00
5/22/2014	Trevor Fetter	CEO	Sell	35,394	$47.52	$1,681,922.88	963,790
5/15/2014	Richard Pettingill	Director	Sell	10,000	$45.22	$452,200.00	16,464
5/12/2014	Edward Kangas	Chairman	Sell	12,000	$44.29	$531,480.00	24,198
4/25/2014	Trevor Fetter	CEO	Sell	57,735	$45.00	$2,598,075.00	999,184
3/24/2014	Audrey Andrews	SVP	Sell	13,624	$40.17	$547,276.08
12/23/2013	Glenview Capital Management, L	major shareholder	Buy	248,910	$39.79	$9,904,128.90
12/20/2013	Glenview Capital Management, L	major shareholder	Buy	644,582	$39.95	$25,751,050.90
12/18/2013	Glenview Capital Management, L	major shareholder	Buy	1,000,000	$40.12	$40,120,000.00
11/15/2013	Keith Pitts	Chairman	Buy	6,250	$43.13	$269,562.50	25,000
11/14/2013	Keith Pitts	Chairman	Buy	6,250	$43.14	$269,625.00	18,750
11/8/2013	Keith Pitts	Chairman	Buy	7,500	$41.85	$313,875.00	12,500
11/7/2013	Keith Pitts	Chairman	Buy	5,000	$41.97	$209,850.00	5,000
10/3/2013	John Ellis Bush	Director	Sell	16,582	$45.10	$747,848.20
9/19/2013	John Ellis Bush	Director	Sell	8,291	$42.90	$355,683.90	36,913
5/14/2013	Glenview Capital Management, L	Major Shareholder	Sell	4,000,000	$47.75	$191,000,000.00
3/5/2013	Edward A Kangas	Chairman	Sell	7,000	$39.88	$279,160.00
3/4/2013	Trevor Fetter	CEO	Sell	138,255	$39.39	$5,445,864.45
10/19/2012	Glenview Capital Management Ll	Major Shareholder	Buy	200,000	$23.53	$4,706,000.00
10/16/2012	Glenview Capital Management Ll	Major Shareholder	Buy	433,383	$23.98	$10,392,524.34
9/17/2012	Glenview Capital Management Ll	Major Shareholder	Buy	750,000	$5.75	$4,312,500.00

(Data available from 1/1/2013 forward)

Tenet Healthcare (NYSE THC) News Headlines

Source:

Date	Headline
	Tenet Healthcare's (THC) Q1 Earnings: Is a Beat in Store? finance.yahoo.com - April 26 at 5:23 PM
	BRIEF-Tenet Healthcare Purchases Remaining 15 pct Ownership Interest In United Surgical Partners International www.reuters.com - April 26 at 5:23 PM
	June 8th Options Now Available For Tenet Healthcare (THC) www.nasdaq.com - April 26 at 5:23 PM
	Tenet Completes Purchase of USPI from WCAS finance.yahoo.com - April 26 at 5:22 PM
	Encoda Hires Industry Veteran to Direct Its Rapidly Growing Revenue Cycle Management Services Division finance.yahoo.com - April 26 at 8:09 AM
	Traders Purchase Large Volume of Call Options on Tenet Healthcare (THC) www.americanbankingnews.com - April 25 at 8:38 AM
	Q1 2018 EPS Estimates for Tenet Healthcare (THC) Cut by Analyst www.americanbankingnews.com - April 25 at 6:54 AM
	Tenet Healthcare (THC) to Release Earnings on Monday www.americanbankingnews.com - April 23 at 7:14 AM
	Tenet beats class action stemming from kickback probe www.reuters.com - April 19 at 8:08 AM
	Zacks: Brokerages Anticipate Tenet Healthcare (THC) Will Announce Quarterly Sales of $4.59 Billion www.americanbankingnews.com - April 18 at 2:26 AM
	Tenet Healthcare (THC) Stock Rating Reaffirmed by SunTrust Banks www.americanbankingnews.com - April 17 at 9:19 AM
	Tenet Healthcare (THC) Expected to Post Earnings of -$0.02 Per Share www.americanbankingnews.com - April 16 at 5:12 PM
	Banner Health agreed to pay $18M to settle false claims act allegations www.bizjournals.com - April 13 at 8:10 AM
	Tenet Healthcare (THC) Receives "Buy" Rating from Jefferies Group www.americanbankingnews.com - April 12 at 7:57 PM
	Tenet Healthcare (THC) Receives "Outperform" Rating from Robert W. Baird www.americanbankingnews.com - April 11 at 5:35 PM
	Tenet Healthcare Corp (THC) Receives Consensus Rating of "Hold" from Brokerages www.americanbankingnews.com - April 11 at 9:43 AM
	Deutsche Bank Reaffirms "Buy" Rating for Tenet Healthcare (THC) www.americanbankingnews.com - April 10 at 8:23 PM
	Tenet Healthcare (THC) Given a $15.00 Price Target at SunTrust Banks www.americanbankingnews.com - April 7 at 12:31 PM
	Tenet Healthcare (THC) Stock Rating Lowered by ValuEngine www.americanbankingnews.com - April 2 at 11:26 PM
	Tenet Healthcare Corp (THC) Short Interest Down 9.9% in March www.americanbankingnews.com - April 2 at 2:52 AM
	Tenet Healthcare Corp (THC) Expected to Announce Quarterly Sales of $4.59 Billion www.americanbankingnews.com - April 1 at 2:16 AM
	Analysts Expect Tenet Healthcare Corp (THC) Will Announce Earnings of -$0.02 Per Share www.americanbankingnews.com - March 30 at 9:16 PM
	Inovalon Announces New Post Acute Care Services Agreement with Tenet Healthcare finance.yahoo.com - March 28 at 8:19 AM
	Tenet Healthcare Sees Unusually High Options Volume (THC) www.americanbankingnews.com - March 28 at 7:22 AM
	Tenet Healthcare Reaches Deal With Glenview Capital Management - Quick Facts www.nasdaq.com - March 27 at 8:16 AM
	Tenet Healthcare (THC) Enters Pact with Glenview Capital www.streetinsider.com - March 26 at 5:27 PM
	Tenet Healthcare up 1.5% premarket after Glenview withdraws bid to change certain bylaws seekingalpha.com - March 26 at 5:27 PM
	Tenet Reaches Agreement with Glenview finance.yahoo.com - March 26 at 8:12 AM
	Tenet Healthcare (THC) Given "Buy" Rating at Mizuho www.americanbankingnews.com - March 22 at 9:20 PM
	How Amedisys’s Business Segments Have Performed finance.yahoo.com - March 19 at 8:12 AM
	Tenet Healthcare Corp (THC) Receives Consensus Recommendation of "Hold" from Analysts www.americanbankingnews.com - March 17 at 10:09 AM
	TheStreet Upgrades Tenet Healthcare (THC) to "C" www.americanbankingnews.com - March 15 at 1:00 PM
	$4.59 Billion in Sales Expected for Tenet Healthcare Corp (THC) This Quarter www.americanbankingnews.com - March 15 at 3:44 AM
	Tenet Healthcare Corp (THC) Director Ashish Dave Sells 75,000 Shares www.americanbankingnews.com - March 14 at 10:41 PM
	"Fast Money" final trades: IBM, JPM and more finance.yahoo.com - March 14 at 7:17 PM
	Tenet Healthcare Corp (THC) Expected to Post Earnings of -$0.02 Per Share www.americanbankingnews.com - March 13 at 5:18 PM
	Tenet Healthcare (THC) Rating Increased to Hold at Zacks Investment Research www.americanbankingnews.com - March 13 at 3:41 PM
	Exploring Tenet Healthcare’s Financial Performance finance.yahoo.com - March 13 at 8:13 AM
	Understanding Tenet Healthcare’s Business Strategy finance.yahoo.com - March 12 at 6:47 PM
	Tenet Announces New Presentation Time for the Barclays Global Healthcare Conference finance.yahoo.com - March 12 at 6:47 PM
	Analyzing the Performances of Tenet’s Business Segments finance.yahoo.com - March 12 at 6:47 PM
	Tenet Healthcare Reaches Analyst Target Price - Nasdaq www.nasdaq.com - March 8 at 8:12 AM
	ValuEngine Upgrades Tenet Healthcare (THC) to Buy www.americanbankingnews.com - March 8 at 12:28 AM
	Tenet Healthcare Corp (THC) to Post Q1 2018 Earnings of $0.03 Per Share, William Blair Forecasts www.americanbankingnews.com - March 7 at 7:32 AM
	Tenet Healthcare (THC) PT Maintained at $30 at Baird on Enhanced Governance Savings; 'Shares Still Mispriced' www.streetinsider.com - March 6 at 5:46 PM
	See what the IHS Markit Score report has to say about Tenet Healthcare Corp. finance.yahoo.com - March 6 at 5:46 PM
	Tenet Healthcare Corp to Post Q3 2018 Earnings of $0.10 Per Share, William Blair Forecasts (THC) www.americanbankingnews.com - March 6 at 8:56 AM
	Tenet Healthcare Sells MacNeal Hospital to Streamline Trade www.zacks.com - March 5 at 5:56 PM
	BRIEF-Tenet Healthcare ‍Board Modifying Bylaws To Reduce Threshold Required To Request Special Meeting www.reuters.com - March 5 at 5:56 PM
	JPMorgan Chase & Co. Reiterates "Sell" Rating for Tenet Healthcare (THC) www.americanbankingnews.com - March 5 at 1:36 PM

Tenet Healthcare (NYSE:THC) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Tenet Healthcare (NYSE:THC) Income Statement, Balance Sheet and Cash Flow Statement

Tenet Healthcare (NYSE THC) Stock Chart for Thursday, April, 26, 2018

Loading chart…

This page was last updated on 4/26/2018 by MarketBeat.com Staff